Inhalable Dry Powder Formulations of the Commercialised Form of Deoxyribonuclease I - a Dried Alternative for the Treatment of Cystic Fibrosis

AuthID
P-01B-DPT
8
Author(s)
Cotter, AB
·
Costa, C
·
Alhajj, N
·
da Silva, JP
·
Mukherjee, S
·
O'Reilly, NJ
·
Padrela, L
Document Type
Article
Year published
2026
Published
in EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, ISSN: 0928-0987
Volume: 220, Pages: 107463 (13)
Indexing
Publication Identifiers
Pubmed: 41679558
Scopus: 2-s2.0-105033864737
Wos: WOS:001701288000001
Source Identifiers
ISSN: 0928-0987
Export Publication Metadata
Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.